FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

Updates in Research and Care: Vaccines and Neuromuscular Conditions: Safety, Science, and Guidance

October 8th, 2025
5:00-6:00pm ET
Live, Virtual Webinar

Join us for a powerful and informative webinar focused on vaccines with neuromuscular disease. Whether you're a person living with a neuromuscular disease, caregiver, or advocate, this webinar will offer valuable insights, resources, and support.

What We’ll Cover:

  • How vaccines are tested and approved.
  • Important considerations related to vaccine safety for people who are immunocompromised.
  • Reasons why certain vaccines are recommended prior to receiving new treatments for neuromuscular disease.
  • Reliable and accurate sources for learners to go to when making decisions about vaccinations for them or their loved ones.
  • Live Q&A with the presenter

Watch On Demand

Meet Our Presenter(s):
Amanda Hernandez, MD, PhD, University of Connecticut
Dr. Smith is a neurologist specializing in neuromuscular disorders with over 15 years of experience in patient care and clinical research.

Not available to join live on October 8th? Register to receive an email when the webinar is available to view on-demand.

If you have questions about this webinar or other MDA programs, please contact the MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.

Faculty: 
Amanda Hernandez, MD, PhD
Amanda Hernandez, MD, PhD
Neurologist

University of Connecticut


Thank you to our supporters:

AlexionBiogen